68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

May 5, 2029

Study Completion Date

May 5, 2029

Conditions
Gastroenteropancreatic Neuroendocrine Tumor
Interventions
DIAGNOSTIC_TEST

68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included

Patients meeting the inclusion criteria will undergo 68Ga-DOTATOC PET(PET/MRI or PET/CT) as part of their routine work-up, according to the referral clinicians' indication.PET/MRI will be performed on a 3.0T time of flight PET/MRI. Simultaneous PET/MRI will start approximately 60 minutes after the injection of 68Ga-DOTATOC.

Trial Locations (1)

20132

RECRUITING

Irccs San Raffaele, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER